GlobeNewswire
Cocrystal Pharma Receives IRB Approval from Emory University School of Medicine for Phase 1b Human Challenge Study with CDI-988 for Prevention and Treatment of Norovirus
📈
AI Sentiment
Highly Positive
8/10
Latest updates and market news for COCP
AI Sentiment
Highly Positive
8/10
Share this news page